Business Context and Reporting Period
Company: Biomerica, Inc. (BMRA)
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2026
Event Date: August 20, 2026 (Agreement); August 26, 2026 (Closing)
Context: The Company entered into a Securities Purchase Agreement to conduct a private placement of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than periodic operating results. Specific metrics include:
- Shares Issued: 1,393,705 shares of common stock.
- Purchase Price: $1.60 per share.
- Gross Proceeds: Approximately $2.23 million.
- Operating Metrics: The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
Material Changes
The primary material change is the increase in outstanding common stock and cash assets resulting from the private placement. Additionally, the Company has entered into new contractual obligations regarding governance and registration rights.
Guidance, Outlook, and Governance
- Investors: The placement included institutional investors (B. Riley Principal Capital, LLC) and certain members of the Board of Directors and executive officers.
- Board Representation: B. Riley Principal Capital, LLC has the right to designate one representative to the Board of Directors as long as it beneficially owns at least 10% of the voting power.
- Lock-Up Agreements: Directors and certain executive officers are restricted from transferring Company securities for 180 days following the closing date.
- Registration Rights: The Company must file a registration statement within 30 days of the closing date. Failure to meet filing or effectiveness obligations may result in liquidated damages of 1.0% of the purchase price per purchaser, capped at 5.0% of the subscription amount.
- Outlook/Guidance: The filing text does not provide updated financial guidance or management commentary on future operating performance.
Investor Verification Checklist
- Verify the exact number of shares issued (1,393,705) and the dilution impact on existing shareholders.
- Confirm the use of proceeds, which is not explicitly detailed in this summary text.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions.
- Monitor the filing of the registration statement required within 30 days of August 26, 2026.
- Check for any subsequent filings regarding the 180-day lock-up expiration for insiders.